Related Experiment Video
Updated: Nov 19, 2025

08:52
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
9.1K
Liposomes embedded with differentiating factors as a new strategy for enhancing DPSC osteogenic commitment
M Gallorini, R Di Carlo, S Pilato
1University "G. d'Annunzio" Chieti-Pescara, 66100, Chieti, Italy.susi.zara@unich.it.
European Cells & Materials
|January 27, 2021
Summary
Liposomes loaded with osteogenic factors accelerate human dental pulp stem cell (DPSC) differentiation into bone cells. This novel Lipo-Mix formulation enhances extracellular matrix deposition and antioxidant responses for tissue engineering applications.
Area of Science:
- Biomaterials Science
- Stem Cell Biology
- Tissue Engineering
Background:
- Human dental pulp stem cells (DPSCs) differentiate into osteoblasts with specific media supplements.
- Liposomes are versatile carriers for biomolecules and drugs.
- Accelerating DPSC osteogenic commitment is crucial for regenerative medicine.
Purpose of the Study:
- To investigate liposomes encapsulating osteogenic factors (ascorbic acid, β-glycerophosphate, dexamethasone) for enhanced DPSC differentiation.
- To evaluate the effect of liposome-encapsulated factors (Lipo-Mix) on DPSC osteogenic commitment and extracellular matrix deposition.
- To assess the impact of Lipo-Mix on cellular redox balance during osteogenesis.
Main Methods:
- Liposomes were prepared and characterized for dimensions.
- DPSC immunophenotypic profiles (CD90, CD73, CD29) were analyzed after Lipo-Mix exposure.
- Alkaline phosphatase activity, Collagen I secretion, and H2O2 levels were measured.
- Extracellular matrix deposition and antioxidant responses were evaluated.
Main Results:
- Lipo-Mix significantly decreased CD90 and enhanced CD73/CD29 expression, indicating osteogenic commitment.
- Increased alkaline phosphatase activity and Collagen I secretion were observed with Lipo-Mix compared to standard medium.
- Lipo-Mix reduced H2O2 release and promoted an early antioxidant response, restoring redox balance.
- Appreciable extracellular matrix deposition was detected in Lipo-Mix treated cells.
Conclusions:
- Liposome-encapsulated osteogenic factors (Lipo-Mix) effectively accelerate DPSC osteogenic commitment.
- Lipo-Mix enhances mineralization, extracellular matrix deposition, and antioxidant capacity in DPSCs.
- This liposomal formulation shows potential for clinical applications in bone tissue engineering.

